Sex | Age at diagnosis (years) | History of migraine | Family history of migraine | Cannabis use | Dose of amitriptyline (mg) | Dose titrated | Remission | Duration of follow- up (years) |
---|---|---|---|---|---|---|---|---|
Female | 22 | Yes | No | No | 10 | No | DNA | DNA |
Female | 22 | No | No | No | 25 | No | Yes | 3 |
Male | 24 | No | No | No | 10 | Up to 35 mg | Yes | 2 |
Female | 19 | No | No | Yes | 10 | Up to 25 mg | Yes | 1 |
Male | 25 | No | No | Yes | 10 | Up to 45 mg | Improved, one further episode | 4 |
Male | 44 | No | No | Yes | 10 | Up to 140 mg | Yes | 5 |
Female | 22 | No | Yes | Yes | 25 | Up to 50 mg | No, continued cannabis use | 1 |
Male | 22 | No | Yes | No | 25 | No | Yes | 1 |
Female | 30 | No | No | No | 25 | Up to 50 mg | Improved, five further episodes | 1 |
Female | 26 | No | Yes | No | 25 | No | DNA | DNA |
Female | 22 | No | No | No | 10 | Up to 20 mg, but reduced due to lethargy | No | 2 |
Female | 28 | No | No | No | 10 | Up to 25 mg | No | 1 |
Female | 22 | No | No | Yes | N/A | N/A | DNA | DNA |
Female | 75 | No | No | No | 25 | No | Yes | 3 |
Female | 55 | No | No | No | N/A | N/A | Yes, without treatment | DNA |
Female | 26 | No | Yes | No | N/A | N/A | Yes, without treatment | 1 |
Female | 22 | No | Yes | No | 25 | Up to 75 mg | DNA | 1 |
DNA, did not attend; N/A; not applicable.